NanoVibronix NAOV 深 沪
等待开盘 11-10 09:30:00 美东时间
4.02
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.02
- 总市值 350.18万
- 52周最高 1950.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 42.60
- 委 比 0.00%
- 总股本 87.11万
- 历史最高 132000.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 264.924
- 每 手 1
- 风险率 4.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ENvue Medical announces 1-for-12 reverse stock split
ENvue Medical (FEED) on Friday announced a 1-for-12 reverse stock split of its issued and outstanding common stock, par value $0.001 per share, effective on September 1, 2026. Following this, the comp...
08-28 20:53
ENvue Medical Completes Move Of NanoVibronix Manufacturing From Israel To The U.S. And Consolidates R&D Operations In Tel Aviv To Lower Opex And Improve Cost Structure
By completing this transition, the Company now manufactures its entire NanoVibronix line in the United States, leveraging these U.S.-based operations to establish a stronger foundation for long-term growth and strategic expansion. The NanoVibronix product line comprises the Company’s acoustic-based ...
08-04 21:04
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
ENvue Medical, a medical device company, has completed the transition of its NanoVibronix manufacturing operations from Israel to the United States and consolidated its R&D operations in Tel Aviv. This move aims to reduce operating expenses, improve cost structure, and enhance operational efficiency. The company now manufactures its entire NanoVibronix product line in the U.S., supporting long-term growth and strategic expansion. The NanoVibronix...
08-04 13:00
EXCLUSIVE: ENvue's FDA-Cleared Tube Placement System Gains Traction In Critical Care Settings
ENvue expands to a US hospital as a Detroit trauma center adopts its FDA-cleared feeding tube navigation system with real-time visualization.
03-24 20:01
ENvue Medical Launches Development And Integration Program Leveraging Vibration-Based Technology From NanoVibronix Division To Address Pain, Discomfort Linked With Indwelling NG Tubes
ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across
01-09 22:05
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
ENvue Medical announces a new program integrating its NanoVibronix vibration technology to address discomfort associated with indwelling nasogastric tubes. The initiative builds on clinical research showing that surface acoustic wave micro-vibration technology can reduce friction during tube use. Though exploratory, the program aims to enhance patient comfort and expand ENvue's enteral care solutions, focusing on technical feasibility and future ...
01-09 14:01
NanoVibronix Rebrands to ENvue Medical, Updates Ticker
NanoVibronix ( ($NAOV) ) has provided an update. On December 12, 2025, NanoVibr...
2025-12-12 22:27
NanoVibronix Elects New Board Members at Annual Meeting
NanoVibronix ( ($NAOV) ) has issued an update. On December 4, 2025, NanoVibroni...
2025-12-05 19:47
NanoVibronix issues letter to shareholders
NanoVibronix (NASDAQ:NAOV) announced on Wednesday the issuance of a letter to shareholders, highlighting the company’s strategic vision, market opportunities, and a rebranding initiative. To reflect ...
2025-11-19 22:43
